Thiogenesis Therapeutics, Corp. — Investor Relations & Filings
Thiogenesis Therapeutics, Corp. is a clinical-stage biotechnology company specializing in the development of New Chemical Entities (NCEs), specifically novel thiol-based prodrugs. These next-generation sulfur-containing therapeutics are designed to restore redox balance and mitigate inflammation, key drivers in inherited and acquired mitochondrial diseases. The company's lead candidate, TTI-0102, is a novel cysteamine prodrug engineered to overcome the limitations of legacy thiol therapies, offering enhanced tolerability, bioavailability, and improved dosing profiles. TTI-0102 is currently being evaluated for unmet pediatric medical needs, including nephropathic cystinosis (with a pivotal Phase 3 trial planned following an expected 2026 IND filing), MELAS (in Phase 2), and other conditions such as Leigh syndrome spectrum.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-11 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-30 | English | |
| 52-109FV1 - Certification of annual filings - CEO (E).pdf | 2026-04-30 | English | |
| Annual MD&A - English.pdf | 2026-04-30 | English | |
| News release - English.pdf | 2026-04-16 | English | |
| News release - English.pdf | 2026-04-16 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
Thiogenesis Therapeutics, Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47770/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47770 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47770 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47770 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47770}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Thiogenesis Therapeutics, Corp. (id: 47770)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.